跳至主要内容
临床试验/IRCT20200326046868N1
IRCT20200326046868N1尚未招募3 期

The effect of propolis supplementation on clinical manifestations and inflammatory biomarkers in patients with COVID-19

Abadan University of Medical Sciences0 个研究点目标入组 88 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Patients aged 18 to 65 years
  • Laboratory confirmation of Covid-19 (2019-nCoV Real-Time RT-PCR)

排除标准

  • Pregnancy and lactation, a history of allergies to honey and bee products, uncontrolled underlying disease including neuropsychiatric problems, diabetes, thyroid disorders, heart disease, chronic liver or kidney failure, and autoimmune diseases.

研究者

发起方
Abadan University of Medical Sciences

相似试验

effect of propolis in COVID-19 | 临床试验